D100G (p.Asp100Gly) variant of SERPINC1 (Antithrombin-III)

D100G (p.Asp100Gly) in SERPINC1 (Antithrombin-III) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Hereditary antithrombin deficiency. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data, published literature, and structural context.

D100G (p.Asp100Gly) variant details